# ClinicalTrials.gov record NCT06918405

> PeptideScanner retained ClinicalTrials.gov record NCT06918405 at 2026-07-30T18:29:04.229Z. Its registry update date was 2025-04-09, and PeptideScanner's reviewed identity mapping was tirzepatide.

- Evidence object: `story:clinicaltrials-gov-nct06918405-tirzepatide:v1`
- Evidence domain: Clinical trials
- Date in source: 2025-04-09
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct06918405-tirzepatide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct06918405-tirzepatide-v1.json
- Content SHA-256: `f485bd07bf362987002288627f26052542f34e1d48c8e0492283edf1eaa91b39`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT06918405 ([`ctg-observation-nct06918405-2025-04-09-b819227ff0a9`](#source-ctg-observation-nct06918405-2025-04-09-b819227ff0a9))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT06918405 at 2026-07-30T18:29:04.229Z. Its registry update date was 2025-04-09, and PeptideScanner's reviewed identity mapping was tirzepatide. ([`ctg-observation-nct06918405-2025-04-09-b819227ff0a9`](#source-ctg-observation-nct06918405-2025-04-09-b819227ff0a9))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT06918405 at 2026-07-30T18:29:04.229Z. Its registry update date was 2025-04-09, and PeptideScanner's reviewed identity mapping was tirzepatide. ([`ctg-observation-nct06918405-2025-04-09-b819227ff0a9`](#source-ctg-observation-nct06918405-2025-04-09-b819227ff0a9))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct06918405-2025-04-09-b819227ff0a9`](#source-ctg-observation-nct06918405-2025-04-09-b819227ff0a9))

## Sources

<a id="source-ctg-observation-nct06918405-2025-04-09-b819227ff0a9"></a>
- **ClinicalTrials.gov record NCT06918405 · retained source version 2025-04-09:b819227ff0a98705ae8f37b1c57c05453d8bf5715026fd00bad422fd09d4a448** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT06918405) (`ctg-observation-nct06918405-2025-04-09-b819227ff0a9`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT06918405." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct06918405-tirzepatide-v1.json SHA-256: f485bd07bf362987002288627f26052542f34e1d48c8e0492283edf1eaa91b39.